Data on the clinical burden of chronic spontaneous urticaria (CSU) and economic consequences are lacking in France. To characterize the clinical and economic burden of CSU in symptomatic patients despite treatment by analysing data of French patients from the ASSURE-CSU study.
In this study are investigated predictive biomarkers of disease evolution in a large cohort of children with seasonal allergic rhinoconjunctivitis (SAR).